OBJECTIVE: To assess the effect of azithromycin mass drug administration regimens on spleen rates in children aged 0-5 years. METHODS: Clinical assessment of spleen size was carried out during a cluster-randomised trial of azithromycin mass treatment for trachoma elimination in The Gambia. Twenty-four communities received three annual mass treatments with azithromycin, and 24 communities received treatment at baseline only. RESULTS: At the 30-month follow-up, 3646 children aged 0-5 years had spleen examination and measurement. Palpable splenomegaly was significantly lower in annually treated vs. baseline-only treatment communities and in treated vs. untreated children at 24 months in the annual treatment arm. CONCLUSION: The results suggest an effect of azithromycin on spleen rates at the individual level and are most plausibly due to the antimalarial effects of azithromycin.
OBJECTIVE: To assess the effect of azithromycin mass drug administration regimens on spleen rates in children aged 0-5 years. METHODS: Clinical assessment of spleen size was carried out during a cluster-randomised trial of azithromycin mass treatment for trachoma elimination in The Gambia. Twenty-four communities received three annual mass treatments with azithromycin, and 24 communities received treatment at baseline only. RESULTS: At the 30-month follow-up, 3646 children aged 0-5 years had spleen examination and measurement. Palpable splenomegaly was significantly lower in annually treated vs. baseline-only treatment communities and in treated vs. untreated children at 24 months in the annual treatment arm. CONCLUSION: The results suggest an effect of azithromycin on spleen rates at the individual level and are most plausibly due to the antimalarial effects of azithromycin.
Authors: Jennifer R Evans; Anthony W Solomon; Rahul Kumar; Ángela Perez; Balendra P Singh; Rajat Mohan Srivastava; Emma Harding-Esch Journal: Cochrane Database Syst Rev Date: 2019-09-26
Authors: Jennifer R Herricks; Peter J Hotez; Valentine Wanga; Luc E Coffeng; Juanita A Haagsma; María-Gloria Basáñez; Geoffrey Buckle; Christine M Budke; Hélène Carabin; Eric M Fèvre; Thomas Fürst; Yara A Halasa; Charles H King; Michele E Murdoch; Kapa D Ramaiah; Donald S Shepard; Wilma A Stolk; Eduardo A Undurraga; Jeffrey D Stanaway; Mohsen Naghavi; Christopher J L Murray Journal: PLoS Negl Trop Dis Date: 2017-08-03
Authors: John D Hart; Lyson Samikwa; Feston Sikina; Khumbo Kalua; Jeremy D Keenan; Thomas M Lietman; Sarah E Burr; Robin L Bailey Journal: Am J Trop Med Hyg Date: 2020-09 Impact factor: 2.345
Authors: Kieran S O'Brien; Sun Y Cotter; Abdou Amza; Boubacar Kadri; Baido Nassirou; Nicole E Stoller; Zhaoxia Zhou; Chris Cotter; Sheila K West; Robin L Bailey; Philip J Rosenthal; Bruce D Gaynor; Travis C Porco; Thomas M Lietman Journal: Am J Trop Med Hyg Date: 2017-07-19 Impact factor: 2.345
Authors: Ahmed M Arzika; Ramatou Maliki; Nameywa Boubacar; Salissou Kane; Catherine A Cook; Elodie Lebas; Ying Lin; Kieran S O'Brien; Ariana Austin; Jeremy D Keenan; Thomas M Lietman; Catherine E Oldenburg Journal: Am J Trop Med Hyg Date: 2020-09 Impact factor: 2.345